Search for 'Provider:Clinical drug investigation,'

Cost of Clinical Management of Acromegaly in Spain.

By Bernal González, Carmen. Clinical Drug Investigation, 2012 . 32(4):235-45. , Formato Vancouver: Roset M, Merino-Montero S, Luque-Ramírez M, Webb SM, López-Mondéjar P, Salinas I et al. Cost of clinical management of acromegaly in Spain. Clin Drug Investig. 2012 Apr 1;32(4):235-45.

Place Hold on Cost of Clinical Management of Acromegaly in Spain.

Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.

By Villacampa Aubá, Felipe . Clinical Drug Investigation, 2012 . 32(8):523-32. , Formato Vancouver: Arlandis S, Ruiz MA, Errando C, Villacampa F, Arumí D, Lizarraga I, et al. Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form. Clin Drug Investig. 2012 Aug 1;32(8):523-32.

Place Hold on Quality of life in patients with overactive bladder: validation and psychometric properties of the Spanish Overactive Bladder Questionnaire-short Form.

Early add-on lacosamide in a real-life setting: results of the REALLY study.

By Saiz Díaz, Rosa Ana. Clinical drug investigation, 2015 . 35(2):121-31. , Formato Vancouver: Villanueva V, Garcés M, López Gomáriz E, Serratosa JM, González Giráldez B, Parra J et al; REALLY Study Group. Early add-on lacosamide in a real-life setting: results of the REALLY study. Clin Drug Investig. 2015 Feb;35(2):121-31.

Place Hold on Early add-on lacosamide in a real-life setting: results of the REALLY study.